SUGAMMADEX SODIUM
MSN · SUGAMMADEX SODIUM
Open FDA's page for this record- Application number
- ANDA214368
- Sponsor name
- MSN
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20260728
- Review priority
- STANDARD
- Submission class code
- UNKNOWN
- Application docs
- ID
- 76687
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/214368Orig1s000TAltr.pdf
- Date
- 20231129
- Type
- Letter
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- SUGAMMADEX SODIUM
- Reference standard
- No
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Te code
- AP
- Active ingredients
- Name
- SUGAMMADEX SODIUM
- Strength
- EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
- Product number
- 002
- Reference drug
- No
- Brand name
- SUGAMMADEX SODIUM
- Reference standard
- No
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Te code
- AP
- Active ingredients
- Name
- SUGAMMADEX SODIUM
- Strength
- EQ 500MG BASE/5ML (EQ 100MG BASE/ML)
- Harmonized identifiers (openFDA)
- Application number
- ANDA214368
- Brand name
- SUGAMMADEX
- Generic name
- SUGAMMADEX
- Manufacturer name
- Novadoz Pharmaceuticals LLC
- Product NDC
- 72205-478, 72205-479
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAVENOUS
- Substance name
- SUGAMMADEX SODIUM
- RxCUI
- 1726992, 1727000
- SPL ID
- 63a0cffd-e2d7-4511-9ab8-923e26981e8e
- SPL set ID
- ab41ea1c-266f-421c-8fc4-6e7ff518a75d
- Package NDC
- 72205-478-01, 72205-478-02, 72205-479-01, 72205-479-02
- UNII
- ERJ6X2MXV7
